Noncoding RNAs in Diabetes

Noncoding RNAs (ncRNAs) have emerged as critical regulators in the pathophysiology of diabetes. Unlike protein-coding RNAs, ncRNAs, including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), play significant roles in gene expression modulation and cellular processes. Research has shown that specific miRNAs are involved in insulin signaling, pancreatic beta-cell function, and glucose metabolism, while lncRNAs contribute to inflammation and fibrosis in diabetic tissues. Dysregulation of these ncRNAs has been linked to the development and progression of diabetes and its complications. Understanding the functions of ncRNAs in diabetes can provide new therapeutic targets for intervention. By manipulating these regulatory pathways, it may be possible to enhance insulin sensitivity, improve beta-cell function, and mitigate the adverse effects of diabetes, ultimately leading to better management strategies for patients.